SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-01-26 11:46
Tx date 2023-01-25
$LOVE
Cannara Biotech Inc.
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$21,000
+200,000 vol
$0.105 each
242,367,820
Filed 2022-12-12 17:24
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$22,500
+125,000 vol
$0.18 each
1,143,700
Filed 2022-12-12 17:17
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$180,000
+1,000,000 vol
$0.18 each
1,000,000
Filed 2022-12-12 17:11
Tx date 2022-11-30
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,563
+23,300 vol
$0.11 each
1,167,000
Filed 2022-12-12 17:10
Tx date 2022-08-02
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,980
+18,000 vol
$0.11 each
1,018,700
Filed 2022-12-12 17:09
Tx date 2022-01-26
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$94.50
+700 vol
$0.135 each
1,000,700
Filed 2022-12-12 17:07
Tx date 2021-10-04
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-12-12 13:51
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$22,500
+125,000 vol
$0.18 each
325,000
Filed 2022-12-01 23:52
Tx date 2022-11-30
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$24,970
+227,000 vol
$0.11 each
2,097,950
Filed 2022-11-30 17:03
Tx date 2022-11-30
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$116,800
+1,000,000 vol
$0.1168 each
11,720,000
Filed 2022-11-29 15:35
Tx date 2022-08-14
$LOVE
Cannara Biotech Inc.
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
Options
50 - Grant of options

+250,000 vol
500,003
Filed 2022-11-29 15:25
Tx date 2022-08-14
$LOVE
Cannara Biotech Inc.
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
Options
50 - Grant of options

+156,000 vol
250,003
Filed 2022-11-29 15:23
Tx date 2022-08-14
$LOVE
Cannara Biotech Inc.
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
Options
50 - Grant of options

+94,000 vol
94,003
Filed 2022-11-29 15:14
Tx date 2022-08-14
$LOVE
Cannara Biotech Inc.
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
3
Filed 2022-11-09 08:22
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$22,500
+125,000 vol
$0.18 each
500,000
Filed 2022-11-07 15:08
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
BEN MOUSSA, ISSAM EDDINE
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2022-10-31 09:59
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Manouk, Anthony
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$22,500
+125,000 vol
$0.18 each
1,625,000
Filed 2022-10-22 21:41
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Durocher, Mary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$9,000
+50,000 vol
$0.18 each
300,000
Filed 2022-10-22 21:39
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Durocher, Mary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$9,000
+50,000 vol
$0.18 each
250,000
Filed 2022-10-10 14:59
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Dupuis, Nicolas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+125,000 vol
1,275,000
Filed 2022-10-05 17:49
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$22,500
+125,000 vol
$0.18 each
1,625,000
Filed 2022-09-30 16:11
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,250,000
+12,500,000 vol
$0.18 each
26,000,000
Filed 2022-09-30 16:04
Tx date 2022-09-29
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$750,000
+7,500,000 vol
$0.10 each
13,500,000
Filed 2022-09-02 16:08
Tx date 2022-08-31
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$80,640
+720,000 vol
$0.112 each
10,720,000
Filed 2022-08-24 10:20
Tx date 2022-08-23
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,900
+49,000 vol
$0.10 each
581,720
Filed 2022-08-24 09:33
Tx date 2022-08-17
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,250
+50,000 vol
$0.105 each
562,000
Filed 2022-08-16 19:09
Tx date 2022-08-12
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$150.00
+1,500 vol
$0.10 each
532,720
Filed 2022-08-11 08:44
Tx date 2022-08-08
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$900.00
+9,000 vol
$0.10 each
531,220
Filed 2022-08-08 11:58
Tx date 2022-08-08
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,750
+100,000 vol
$0.1075 each
512,000
Filed 2022-08-06 08:38
Tx date 2022-08-03
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$20,000
+200,000 vol
$0.10 each
522,220
Filed 2022-05-25 14:22
Tx date 2022-05-24
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$24,200
+220,000 vol
$0.11 each
1,870,950
Filed 2022-05-10 12:55
Tx date 2022-05-10
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$24,000
+200,000 vol
$0.12 each
322,220
Filed 2022-05-06 23:23
Tx date 2022-05-04
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,500
+150,000 vol
$0.11 each
1,650,950
Filed 2022-02-28 10:52
Tx date 2022-02-23
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,150
+10,000 vol
$0.115 each
122,220
Filed 2022-02-10 16:34
Tx date 2022-02-10
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,875
+47,000 vol
$0.125 each
1,500,950
Filed 2022-01-27 14:49
Tx date 2022-01-27
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$33,280
+256,000 vol
$0.13 each
1,453,950
Filed 2022-01-27 11:45
Tx date 2022-01-26
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,725
+35,000 vol
$0.135 each
412,000
Filed 2022-01-17 07:52
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Dupuis, Nicolas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,000,000 vol
1,150,000
Filed 2022-01-17 07:41
Tx date 2021-07-27
$LOVE
Cannara Biotech Inc.
Dupuis, Nicolas
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
150,000
Filed 2022-01-12 10:45
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Manouk, Anthony
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$180,000
+1,000,000 vol
$0.18 each
1,500,000
Filed 2022-01-10 22:29
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,000,000 vol
1,000,000
Filed 2022-01-10 22:19
Tx date 2021-10-04
$LOVE
Cannara Biotech Inc.
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-13 15:31
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$9,000
+50,000 vol
$0.18 each
150,000
Filed 2021-12-13 13:06
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Abitbol, David
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$180,000
+1,000,000 vol
$0.18 each
1,500,000
Filed 2021-12-13 12:57
Tx date 2021-02-01
$LOVE
Cannara Biotech Inc.
Abitbol, David
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+500,000 vol
$0.18 each
500,000
Filed 2021-12-13 12:51
Tx date 2020-12-22
$LOVE
Cannara Biotech Inc.
Abitbol, David
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-13 07:57
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$22,500
+125,000 vol
$0.18 each
375,000
Filed 2021-12-13 07:53
Tx date 2020-11-10
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2021-12-11 12:12
Tx date 2020-05-15
$LOVE
Cannara Biotech Inc.
Durocher, Mary
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2021-12-10 16:49
Tx date 2021-07-27
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$36,000
+200,000 vol
$0.18 each
200,000
Filed 2021-12-10 16:02
Tx date 2021-04-01
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 16:01
Tx date 2020-03-25
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,000
+10,000 vol
$0.70 each
10,000
Filed 2021-12-10 15:47
Tx date 2021-05-28
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,050
+7,500 vol
$0.14 each
462,500
Filed 2021-12-10 15:46
Tx date 2021-05-28
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,125
+75,000 vol
$0.135 each
455,000
Filed 2021-12-10 15:46
Tx date 2021-05-26
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,400
+80,000 vol
$0.13 each
380,000
Filed 2021-12-10 15:45
Tx date 2021-05-26
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,125
+75,000 vol
$0.135 each
300,000
Filed 2021-12-10 15:45
Tx date 2021-05-25
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,125
+75,000 vol
$0.135 each
225,000
Filed 2021-12-10 15:44
Tx date 2021-05-21
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,125
+75,000 vol
$0.135 each
150,000
Filed 2021-12-10 15:44
Tx date 2021-05-20
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,125
+75,000 vol
$0.135 each
75,000
Filed 2021-12-10 15:37
Tx date 2021-04-01
$LOVE
Cannara Biotech Inc.
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 14:15
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$450,000
+2,500,000 vol
$0.18 each
6,000,000
Filed 2021-12-10 14:00
Tx date 2021-12-07
$LOVE
Cannara Biotech Inc.
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$180,000
+1,000,000 vol
$0.18 each
1,500,000
Filed 2021-12-09 17:04
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$23,907,968
+153,650,184 vol
$0.1556 each
163,650,184
Filed 2021-12-09 17:03
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$23,907,968
+153,650,184 vol
$0.1556 each
Filed 2021-12-09 16:50
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$23,907,968
+153,650,184 vol
$0.1556 each
163,650,184
Filed 2021-12-09 16:50
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$23,907,968
+153,650,184 vol
$0.1556 each
Filed 2021-12-09 16:48
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
10,000,000
Filed 2021-12-09 16:46
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,198
+43,909,972 vol
$0.0911 each
Filed 2021-12-09 16:45
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
Filed 2021-12-09 16:45
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-09 16:44
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,198
+43,909,972 vol
$0.0911 each
Filed 2021-12-09 16:40
Tx date 2020-07-06
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$251,799
+2,517,990 vol
$0.10 each
Filed 2021-12-09 16:27
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Richard
6 - Director or Senior Officer of 10% Security Holder
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
163,650,184
Filed 2021-12-09 16:16
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
Filed 2021-12-09 16:11
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
Filed 2021-12-09 15:58
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
Filed 2021-12-09 15:58
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
161,132,194
Filed 2021-12-09 15:50
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,198
+43,909,972 vol
$0.0911 each
Filed 2021-12-09 15:50
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,198
+43,909,972 vol
$0.0911 each
53,909,972
Filed 2021-12-09 15:47
Tx date 2020-07-06
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$251,799
+2,517,990 vol
$0.10 each
Filed 2021-12-09 15:47
Tx date 2020-07-06
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$251,799
+2,517,990 vol
$0.10 each
56,427,962
Filed 2021-12-09 15:35
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-09 15:35
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
10,000,000
Filed 2021-12-09 15:27
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,198
+43,909,972 vol
$0.0911 each
Filed 2021-12-09 15:27
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,198
+43,909,972 vol
$0.0911 each
53,909,972
Filed 2021-07-02 16:47
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
Filed 2021-07-02 16:47
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
Filed 2021-07-02 16:01
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Richard
6 - Director or Senior Officer of 10% Security Holder
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-21 12:44
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,152
+43,909,472 vol
$0.0911 each
Filed 2020-02-21 12:44
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,152
+43,909,472 vol
$0.0911 each
Filed 2021-08-27 13:04
Tx date 2021-08-27
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,405
+57,000 vol
$0.165 each
1,197,950
Filed 2021-08-27 13:03
Tx date 2021-08-24
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,220
+68,000 vol
$0.165 each
1,140,950
Filed 2021-08-23 09:36
Tx date 2021-08-10
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$990.00
+6,000 vol
$0.165 each
86,000
Filed 2021-08-23 09:22
Tx date 2021-08-20
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$4,457
+26,220 vol
$0.17 each
112,220
Filed 2021-08-05 11:18
Tx date 2021-08-05
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,500
+150,000 vol
$0.17 each
377,000
Filed 2021-07-09 14:18
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Olymbec Investments Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
161,131,694
Filed 2021-07-02 16:47
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$19,299,999
+107,222,222 vol
$0.18 each
161,131,694
Filed 2021-07-02 16:01
Tx date 2021-06-21
$LOVE
Cannara Biotech Inc.
Stern, Richard
6 - Director or Senior Officer of 10% Security Holder
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
161,131,694
Filed 2021-05-17 15:39
Tx date 2021-05-14
$LOVE
Cannara Biotech Inc.
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$49,000
+350,000 vol
$0.14 each
1,072,950
Filed 2021-05-06 11:25
Tx date 2021-05-06
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,890
+82,000 vol
$0.145 each
227,000
Filed 2021-05-06 11:24
Tx date 2021-05-05
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,610
+18,000 vol
$0.145 each
145,000
Filed 2021-04-14 15:01
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
231,832,194
Filed 2020-08-20 18:10
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-01-09 12:17
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-05 15:37
Tx date 2020-05-01
$LOVE
Cannara Biotech Inc.
Manouk, Anthony
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2021-02-26 07:52
Tx date 2020-12-15
$LOVE
Cannara Biotech Inc.
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$45,000
+250,000 vol
$0.18 each
500,000
Filed 2021-02-26 07:50
Tx date 2020-11-09
$LOVE
Cannara Biotech Inc.
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2021-02-24 10:35
Tx date 2021-02-23
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,400
+60,000 vol
$0.14 each
80,000
Filed 2021-02-08 08:55
Tx date 2021-02-04
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,400
+20,000 vol
$0.12 each
20,000
Filed 2021-02-08 08:54
Tx date 2020-11-10
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-08 08:54
Tx date 2021-02-04
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,605
+127,000 vol
$0.115 each
127,000
Filed 2021-02-08 08:52
Tx date 2020-11-10
$LOVE
Cannara Biotech Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-11-10 23:15
Tx date 2020-11-10
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
3,500,000
Filed 2020-11-10 22:46
Tx date 2020-11-10
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
722,950
Filed 2020-10-19 16:58
Tx date 2020-10-15
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,750
+150,000 vol
$0.085 each
591,078
Filed 2020-10-02 14:08
Tx date 2020-10-01
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$680.00
+8,000 vol
$0.085 each
441,078
Filed 2020-09-24 13:42
Tx date 2020-09-23
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,015
+59,000 vol
$0.085 each
433,078
Filed 2020-09-17 10:47
Tx date 2020-09-14
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,360
+51,300 vol
$0.085 each
374,078
Filed 2020-08-20 18:10
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
231,761,250
Filed 2019-01-09 12:17
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-28 11:59
Tx date 2019-04-25
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$18,000
+100,000 vol
$0.18 each
100,000
Filed 2020-02-28 11:58
Tx date 2019-04-08
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-28 11:58
Tx date 2020-02-04
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$155,000
+1,000,000 vol
$0.155 each
2,190,000
Filed 2020-02-28 11:55
Tx date 2020-02-03
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$29,450
+190,000 vol
$0.155 each
1,190,000
Filed 2020-02-28 11:54
Tx date 2020-02-03
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$165,000
+1,000,000 vol
$0.165 each
1,000,000
Filed 2020-02-28 11:54
Tx date 2019-12-27
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-115,862.50
-1,007,500 vol
$0.115 each
0
Filed 2020-02-28 11:53
Tx date 2019-12-24
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,720
-31,000 vol
$0.12 each
1,007,500
Filed 2020-02-28 11:53
Tx date 2019-12-23
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,280
-69,000 vol
$0.12 each
1,038,500
Filed 2020-02-28 11:52
Tx date 2019-12-20
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-43,500
-362,500 vol
$0.12 each
1,107,500
Filed 2020-02-28 11:52
Tx date 2019-12-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-164,920
-1,330,000 vol
$0.124 each
1,470,000
Filed 2020-02-28 11:51
Tx date 2019-04-08
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,800,000
Filed 2020-02-21 12:44
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$4,000,152
+43,909,472 vol
$0.0911 each
53,909,472
Filed 2020-02-20 15:22
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Laxer, Barnett
5 - Senior Officer of Issuer
Holder: Radical Design Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$1,250,047
+13,721,711 vol
$0.0911 each
13,721,711
Filed 2020-02-20 15:19
Tx date 2019-08-14
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Laxer, Barnett
5 - Senior Officer of Issuer
Holder: Radical Design Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-20 15:16
Tx date 2020-02-19
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$743,524
+8,161,626 vol
$0.0911 each
242,167,820
Filed 2020-02-07 12:00
Tx date 2019-08-14
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Laxer, Barnett
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
15,000,000
Filed 2020-02-07 11:58
Tx date 2019-08-14
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Laxer, Barnett
5 - Senior Officer of Issuer
Holder: JCJ Family Trust (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
12,000,000
Filed 2020-01-21 13:28
Tx date 2020-01-16
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Abramovitch, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$27,000
+150,000 vol
$0.18 each
150,000
Filed 2020-01-21 13:27
Tx date 2020-01-16
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Abramovitch, David
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-15 16:42
Tx date 2019-08-15
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,185
+27,000 vol
$0.155 each
234,006,194
Filed 2019-08-15 16:41
Tx date 2019-08-15
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$14,729
+98,000 vol
$0.1503 each
233,979,194
Filed 2019-08-09 15:31
Tx date 2019-08-09
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$62,202
+422,000 vol
$0.1474 each
233,881,194
Filed 2019-08-08 11:21
Tx date 2019-08-07
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$47,299
+345,000 vol
$0.1371 each
233,459,194
Filed 2019-03-14
Tx date 2019-03-13
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,100
+45,000 vol
$0.18 each
322,778
Filed 2019-03-14
Tx date 2019-03-13
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$238,323
+1,282,000 vol
$0.1859 each
233,114,194
Filed 2019-01-31
Tx date 2019-01-30
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Carroll, Donal
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-98,500
-500,000 vol
$0.197 each
0
Filed 2019-01-14
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Bokhari, Raza
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,807,361
Filed 2019-01-11
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Durkacz, Anthony John
3 - 10% Security Holder of Issuer
Holder: Fortius Research and Trading Corp. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
4,000,000
Filed 2019-01-11
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Durkacz, Anthony John
3 - 10% Security Holder of Issuer
Holder: First Republic Capital Corp. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
4,042,945
Filed 2019-01-11
Tx date 2018-12-31
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.)
Durkacz, Anthony John
3 - 10% Security Holder of Issuer
Holder: First Republic Capital Corp. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
1,341,877